pio3-shutterstock-com
pio3 / Shutterstock.com
15 March 2016Asia

Médecins Sans Frontières fears Pfizer’s monopoly over pneumonia vaccine

Activist organisation Médecins Sans Frontières (MSF) has challenged Pfizer’s patent application covering the pneumococcal conjugate vaccine on the grounds that it is obvious.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
2 March 2016   Médecins Sans Frontières has urged the Indian Patent Office to reject a Gilead Sciences patent application covering Sovaldi.
Asia-Pacific
10 May 2016   Gilead has been granted a patent for its hepatitis C drug Sovaldi in India, despite concerns over the cost of the drug.

More on this story

Asia
2 March 2016   Médecins Sans Frontières has urged the Indian Patent Office to reject a Gilead Sciences patent application covering Sovaldi.
Asia-Pacific
10 May 2016   Gilead has been granted a patent for its hepatitis C drug Sovaldi in India, despite concerns over the cost of the drug.

More on this story

Asia
2 March 2016   Médecins Sans Frontières has urged the Indian Patent Office to reject a Gilead Sciences patent application covering Sovaldi.
Asia-Pacific
10 May 2016   Gilead has been granted a patent for its hepatitis C drug Sovaldi in India, despite concerns over the cost of the drug.